What is the Cancer Drug List (CDL) and why?
To address this issue, MOH has created the Cancer Drug List (CDL), which is a list of approved cancer drugs that can be claimed from your MediSave, MediShield, and one’s integrated Shield policy. The changes have already been implemented for MediSave and MediShield from September 2022,...Cancer is a disease that affects millions of people around the world, and it can be very costly to treat. In Singapore, the Ministry of Health (MOH) conducted a review of MediShield Life in 2020 and found that the cost of cancer treatment was increasing at a shocking rate of 20% per annum compounded each year. This staggering increase each year means that treatment costs will continue to escalate quickly, and premiums for healthcare insurance will also increase drastically unless something is done to control these rising costs.
